GlassScriptPhysician profile
Joana H Magno
NPI 1447266655
$23,007.54
in general payments reported to CMS, 2019-2025
34 companies · $1,700 in 2025
The $1,700 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,708 · 2020: $2,581 · 2021: $2,467 · 2022: $3,650 · 2023: $3,240 · 2024: $3,662 · 2025: $1,700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,122 · Travel and Lodging: $461 · Education: $17.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,122.41 |
| Travel and Lodging | $461.40 |
| Education | $17.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $4,206.96 | 2019-2024 | Renamic Neo, Orsiro Mission, Pk Papyrus |
| Abiomed | $3,384.83 | 2019-2025 | Impella |
| Abbott Laboratories | $1,989.44 | 2019-2025 | Jot Dx, Dragonfly Opstar, Xience Skypoint |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,631.93 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $1,561.66 | 2019-2024 | Xarelto |
| Shockwave Medical, INC | $1,544.85 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $1,351.93 | 2019-2024 | Rotablator Rotational Atherectomy System Console Kit, Synergy |
| Astrazeneca Pharmaceuticals LP | $926.59 | 2019-2025 | Lokelma, Brilinta, Farxiga |
| Impulse Dynamics (USA) INC. | $571.55 | 2021-2024 | Optimizer, Optimizer |
| Inari Medical, INC. | $560.02 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $553.14 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $506.53 | 2022-2025 | |
| Novo Nordisk INC | $459.01 | 2021-2025 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $434.17 | 2019-2024 | |
| Amarin Pharma, INC. | $383.12 | 2019-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $380.15 | 2019-2025 | Camzyos |
| Esperion Therapeutics, INC. | $365.23 | 2020-2025 | Nexletol |
| Teleflex LLC | $340.54 | 2022-2025 | Guideliner, Turnpike |
| Amgen INC. | $328.78 | 2019-2025 | Repatha, Repatha, Otezla |
| Merck Sharp & Dohme LLC | $239.35 | 2022-2024 | Verquvo |
| Philips North America LLC | $220.31 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $167.62 | 2019 | |
| Heartflow, INC. | $165.90 | 2024 | |
| Atricure, INC. | $148.55 | 2019 | |
| Medtronic Vascular, INC. | $133.97 | 2019 | |
| Sanofi-Aventis U.S. LLC | $120.19 | 2019 | |
| Pfizer INC. | $78.58 | 2020-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $62.83 | 2024 | Arcalyst |
| Kowa Pharmaceuticals America, INC. | $51.46 | 2019 | |
| Gilead Sciences, INC. | $42.19 | 2019 | |
| Baxter Healthcare | $30.24 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Dexcom, INC. | $25.33 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $24.43 | 2023 | Inpefa |
| Inspire Medical Systems, INC. | $16.16 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joana Magno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.